BARDA boosts Pfenex anthrax vaccine award

04:20 EDT 2 Oct 2013 | SCRIP

The vaccine candidate is based on rPA produced with the company's platform Pfenex Expression Technology.

Original Article: BARDA boosts Pfenex anthrax vaccine award

NEXT ARTICLE

More From BioPortfolio on "BARDA boosts Pfenex anthrax vaccine award"

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

Vaccine
Latest News Clinical Trials Research Drugs Reports Corporate
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...

Advertisement

Searches Linking to this Story